Understanding kidney protection mechanisms in mouse models of a genetic kidney disease.
Decoding reno-protective mechanisms in mouse Pkhd1 models: Implications for ARPKD therapeutics
This study is looking at how certain proteins help protect kidneys in mice with a genetic condition called ARPKD, which causes serious kidney problems, to find out why mice don’t get as sick as people do, and the hope is that this could lead to new treatments for those living with ARPKD.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Children's Research Institute NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project ID | NIH-10817867 on NIH RePORTER |
What this research studies
This research investigates the mechanisms that protect kidneys in mouse models of autosomal recessive polycystic kidney disease (ARPKD), a condition that leads to severe kidney dysfunction. By studying how mutations in the PKHD1 gene affect kidney function, the researchers aim to uncover why mice with similar mutations do not exhibit the same severe symptoms as humans. The approach involves analyzing the role of a protein called fibrocystin/polyductin and its interactions within kidney cells. Insights gained from these studies could lead to new therapeutic strategies for patients suffering from ARPKD.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with autosomal recessive polycystic kidney disease (ARPKD).
Not a fit: Patients with other types of kidney diseases unrelated to ARPKD may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments that improve kidney function and quality of life for patients with ARPKD.
How similar studies have performed: Previous research has shown promising results in understanding kidney disease mechanisms through genetic models, suggesting that this approach could yield valuable insights.
Where this research is happening
Washington, United States
- Children's Research Institute — Washington, United States (Active)
Researchers
- Principal investigator: Caldovic, Ljubica Morizono — Children's Research Institute
- Study coordinator: Caldovic, Ljubica Morizono
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.